Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net earnings (loss) $ 245 $ 52
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:    
Depreciation and amortization 241 260
Stock-based compensation 61 56
Non-cash impairment and restructuring costs 1 8
Share of (earnings) loss of affiliates, net 19 10
Realized and unrealized (gains) losses on financial instruments, net 3 46
Deferred income tax expense (benefit) (21) (6)
Other charges (credits), net 26 2
Changes in operating assets and liabilities    
Current and other assets (27) 65
Payables and other liabilities (153) 168
Net cash provided (used) by operating activities 395 661
Cash flows from investing activities:    
Investments in equity method affiliates and debt and equity securities (180) (169)
Cash proceeds from dispositions   34
Cash (paid) received for acquisitions, net of cash acquired (205)  
Capital expended for property and equipment, including internal-use software and website development (201) (281)
Other investing activities, net (64) 1
Net cash provided (used) by investing activities (650) (415)
Cash flows from financing activities:    
Borrowings of debt 230 1,479
Repayments of debt (277) (1,690)
Subsidiary shares repurchased by subsidiary   (62)
Cash dividends paid by subsidiary (17) (17)
Taxes paid in lieu of shares issued for stock-based compensation (24) (24)
Other financing activities, net 6 57
Net cash provided (used) by financing activities (82) (257)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash   2
Net increase (decrease) in cash, cash equivalents and restricted cash (337) (9)
Cash, cash equivalents and restricted cash at beginning of period 2,028 2,276
Cash, cash equivalents and restricted cash at end of period $ 1,691 $ 2,267